In line with the decreased trend of M1 macrophage ratio, high-dose topiramate significantly down-regulated the expression of tumor necrosis factor-α (TNF-α), IL-1β and matrix metalloproteinase (MMP)-9 as well as decreased MMP-9 activity, which contributes to the development of AAA formation. Here, MMP9 is linked to triple-A syndrome.